APA (7th ed.) Citation

Forero‐Torres, A., Leonard, J. P., Younes, A., Rosenblatt, J. D., Brice, P., Bartlett, N. L., . . . Gopal, A. K. (2009). A Phase II study of SGN‐30 (anti‐CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma. British journal of haematology, 146(2), 171-179. https://doi.org/10.1111/j.1365-2141.2009.07740.x

Chicago Style (17th ed.) Citation

Forero‐Torres, Andres, et al. "A Phase II Study of SGN‐30 (anti‐CD30 MAb) in Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma." British Journal of Haematology 146, no. 2 (2009): 171-179. https://doi.org/10.1111/j.1365-2141.2009.07740.x.

MLA (9th ed.) Citation

Forero‐Torres, Andres, et al. "A Phase II Study of SGN‐30 (anti‐CD30 MAb) in Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma." British Journal of Haematology, vol. 146, no. 2, 2009, pp. 171-179, https://doi.org/10.1111/j.1365-2141.2009.07740.x.